Recently Viewed
Clear All

Sun Pharmaceutical Industries Ltd.

factsheet Factsheet
  • Market Capitalisation market-capitalisation-info ₹2,95,418 Cr
  • Price to Earnings Ratio price-to-earning 34.56
  • 12 Month Earnings monthly-earning ₹8,549 Cr

Sun Pharmaceutical Industries Ltd. Share Price

₹1,231.25

As on 01-Dec-2023 IST

up-down-arrow ₹5.40 • 0.44%

  • Prev Close info

    ₹1,225.85

  • Day's Openinfo

    ₹1,233.05

  • Today's Highinfo

    ₹1,241.85

  • Today's Lowinfo

    ₹1,225.00

  • Today's Volumeinfo

    17,49,751

  • 52 Week rangeinfo

    ₹922.45 - 1,241.85

Sun Pharmaceutical Industries Ltd. Stock Performance
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Sun Pharmaceutical
22.95 13.10 10.76 17.70 34.01 20.11 7.97
S&P BSE Sensex
10.91 5.65 4.09 6.94 15.19 13.27 12.49
S&P BSE Healthcare
32.32 11.76 9.26 27.28 14.47 16.29 12.36
As on 01-Dec-2023
2022
2021
2020
2019
2018
2017
2016
Sun Pharmaceutical
18.41 41.84 36.39 -0.23 -25.01 -9.34 -22.75
S&P BSE Sensex
4.44 21.99 15.75 14.38 5.87 27.91 1.95
S&P BSE Healthcare
-12.10 20.87 61.45 -3.55 -5.89 0.49 -12.88

Valuation
Stock
Peer Median

Growth & Efficiency
Stock
Peer Median

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

More Details about Key Ratiosarrow

Sun Pharmaceutical Industries Ltd. Peer Comparison

search
search
search
search
    See More Peer Comparisonsarrow

    Valuation Chart of Sun Pharmaceutical Industries Ltd.

        Financials

        See More Financial Detailsarrow

        Shareholding Pattern

        See More Details of Holdingsarrow

        News & Analysis of Sun Pharmaceutical Industries Ltd.

        a-hunt-for-quality-large-caps-available-cheap

        A hunt for quality large caps available cheap

        By Jugal Harpalani

        steely-discipline

        Steely discipline

        value-your-funds

        Value your funds

        By Kumar Shankar Roy

        more-than-meets-the-eye

        More than meets the eye

        By Yash Rohra

        the-unusual-five

        The unusual five

        By Mohammed Ekramul Haque

        a-bit-of-everything

        A bit of everything

        See More Details arrow

        Other details of Sun Pharmaceutical Industries Ltd.

        Incorporated

        1993

        Chairman

        --

        Managing Director

        Dilip S Shanghvi

        Group

        Sun Pharma

        Headquarters

        Vadodara, Gujarat

        Website

        www.sunpharma.com
        More Detailsarrow

        FAQs for Sun Pharmaceutical Industries Ltd.

        The total asset value of Sun Pharmaceutical Industries Ltd. stood at ₹ 79,441 Cr as on 30-Sep-23

        The share price of Sun Pharmaceutical Industries Ltd. is ₹1,231.25 (NSE) and ₹1,231.25 (BSE) as of 01-Dec-2023 IST. Sun Pharmaceutical Industries Ltd. has given a return of 34.01% in the last 3 years.

        Sun Pharmaceutical Industries Ltd. has a market capitalisation of ₹ 2,95,418 Cr as on 01-Dec-2023. As per Value Research classification, it is a Large Cap company.

        The P/B ratio of Sun Pharmaceutical Industries Ltd. is 4.94 times as on 01-Dec-2023, a 0.51% premium to its peers’ median range of 3.28 times.

        The P/E ratio of Sun Pharmaceutical Industries Ltd. is 34.56 times as on 01-Dec-2023, a 0.15% premium to its peers’ median range of 30.01 times.

        Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
        Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
        Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
        Step 4. Search for the Sun Pharmaceutical Industries Ltd. and enter the required number of quantities and click on buy to purchase the shares of Sun Pharmaceutical Industries Ltd..

        Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology, neuropsychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It provides APIs for anti-cancers, peptides, steroids, hormones, and immunosuppressant drugs. In addition, the company offers generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, and anti retro viral medications, as well as over-the-counter products. The company was founded in 1983 and is based in Mumbai, India.

        The promoters of Sun Pharmaceutical Industries Ltd. are Shanghvi Finance Private Limited and Dilip Shantilal Shanghvi. They collectively own 49.9 per cent of the total equity. The chairman of the company is

        The promoters of Sun Pharmaceutical Industries Ltd. have pledged 1.33% of the total equity as on Sep-23.

        Some of the close peers are:

        Company Market Cap(₹ Cr)
        Divi's Laboratories
        1,00,675
        Cipla
        97,419
        Dr. Reddy's Laboratories
        95,867
        Torrent Pharmaceuticals
        72,810
        Sun Pharmaceutical Industries Ltd. Ratios
        Return on equity(%)
        15.48
        Return on capital employed(%)
        --
        Debt-to-equity ratio
        0
        Dividend yield(%)
        0.93

        Yes, TTM profit after tax of Sun Pharmaceutical Industries Ltd. was ₹8,549 Cr.

        Stock Screeners

        Select stocks based on pre-defined filters or customised as per your needs.
        stocks-selector-icon

        Market Monitor

        Returns of all major Indian and Global equity indices across time periods.
        indices-icon

        Who Owns What?

        Search a company by name to view which funds hold its shares.
        who-owns-what-icon

        My Investments

        Elevate your portfolio with detailed analytics, powerful tools and handpicked recommendations. See how all your investments are performing.
        my_investment

        My Watchlist

        Keep an eye on the investments you wish to invest in
        watchlist_icon

        SIP Calculator

        Calculate how much you can accumulate with your monthly savings.
        wealth-selector-icon
        See All Tools right-arrow
        Edit peer-selector-edit

        Key Facts

        • Market cap market-cap-information ₹2,95,418.12 Cr
        • Revenue (TTM)revenue-information ₹46,304.89 Cr
        • Earnings (TTM) earning-information ₹8,548.53 Cr
        • Cash date-information ₹14,833.25 Cr
        • Total Debt info ₹6,197.88 Cr
        • Promoters' ownership promoters_ownership 54.48%
        • Liquidity liquidity High
        • 52 Week range week-range ₹922.45 - 1,241.85
        • Face value face-value ₹1.00
        • Shares outstanding share-outstanding 2,39,93,34,970
        • 10 Years Aggregate:

          CFO: ₹56,115.62 Cr

          EBITDA: ₹81,282.58 Cr

          Net Profit: ₹47,075.76 Cr

        About The Company

        • Incorporated 1993
        • Chairman --
        • Managing Director Dilip S Shanghvi
        • Group Sun Pharma
        • Listing key-listing BSE: 524715, NSE: SUNPHARMA
        • Country India
        • Headquarters headquarters Vadodara, Gujarat
        • Website website www.sunpharma.com
        • Business

          Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations...  in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology, neuropsychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It provides APIs for anti-cancers, peptides, steroids, hormones, and immunosuppressant drugs. In addition, the company offers generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, and anti retro viral medications, as well as over-the-counter products. The company was founded in 1983 and is based in Mumbai, India.  Read more

        Demystifying Stocks.

        At Value Research, we believe it's best to understand investments before diving in. And since 1990, we've been doing exactly that – helping & guiding lakhs of Indians with their investing journey. Join the journey.

        Sign Up for Free
        demystifying-mutual-fund

        What can Value Research do for you?

        solidify-your-fundamentals
        Solidify your fundamentals

        Learn the principles, mindset and tools you need to become a successful Mutual Fund and Stock investor from the masters who have been doing this for decades.

        track-all-your-investments
        Track all your investments

        Use India's most advanced investment tracker to track, analyse and get updates and insights on your investments.

        get-guidance-from-our-experts
        Get guidance from our experts

        Get an analysis of your portfolio along with actionable, general tips and insights, guidance on where to invest based on your goals, and experts' opinions on individual Mutual Funds and Stocks.

        get-access-to-exclusive-analytics
        Get access to exclusive analytics

        Value Research offers the most advanced and detailed data & analytics available on Mutual Funds and Stocks. Sign up and unlock the power yourself.

        Explore All Features page-redirect-arrow

        Explore it yourself, for free

        Sign up and get access to:

        Unlimited access to advice from India's top experts

        The most comprehensive analysis of funds and stocks in India

        A holistic portfolio manager to help track all your investments easily

        And much more, like guides, tools, webinars, videos and eBooks.

        Sign Up for Free
        by-stockAdd Portfolio watchlist-stock-modal Add to watchlist share-fund-plan-icon